• OBJECTIVES

    To develop and maintain a Phase IV Safety and Effectiveness Studies Platform in Africa
     
    To assess the effectiveness of new malaria treatments and its determinants in real life health systems in Africa
     
    To evaluate safety of new malaria treatments through comprehensive pharmacovigilance in an African h...

  • GOAL

    To facilitate adoption of new anti-malarials by providing national, regional and international health decision makers with independent and objective evidence on the safety and effectiveness of new antimalarial drugs as a basis for malaria treatment policy in Africa

  • Attributable benefits

    This project will:

    >> improve the utility of investments to replace the failing arsenal of antimalarial drugs in Africa
    >> minimize the time gap between licensure and adoption of new anti-malarials
    >> improve the performance of African health systems for effective malaria case management
    >> reduce preventable morbidity and mortality

INESS UPDATES

EVENTS

  • 15/02/2010 - 17/02/2010 : Data analysis Workshop
    INESS data analysis workshop, Accra Ghana
  • 10/03/2010 - 12/03/2010 : Journalists Training
    Journalists training workshop, Ifakara Tanzania
  • 29/03/2010 - 31/03/2010 : INESS GCB and SRB
    INESS Governance Council Board and Scientific Review Board Meetings, Dar es Salaam Tanzania

NEWS

  • Comming Soon!
About us

 

The INDEPTH Effectiveness and Safety Studies of Anti-malarial Drugs in Africa (INESS) is an exciting new platform that aims to enable African researchers to carry out a large phase IV trials.  This will result into systematic, evidence-based reviews of the comparative effectiveness and safety of malaria drugs in many widely used drug classes, and to apply the findings to inform public policy and related activities in local settings.



This kind of Phase IV studies for antimalarials has not previously taken place in Africa under the direction of African researchers. It will provide objective country-specific effectiveness and safety data to inform global and national policy and practice and will speed up access to evidence on treatment effectiveness and safety. INESS will also enhance African capacity to monitor local health systems in order to the track the costs, effectiveness of coverage, and impact of newly registered antimalarial treatments.  Overall, INESS aims to reduce the time gap between the licensing of a new drug and its introduction into health systems for use
 

GOAL

To facilitate adoption of new anti-malarials by providing national, regional and international health decision makers with independent and objective evidence on the safety and effectiveness of new antimalarial drugs as a basis for malaria treatment policy in Africa